This project is part of the AIMS-2-TRIALS research program. Click here to explore the website and learn about the scientific research being carried out by the AIMS-2-TRIALS consortium.

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777394. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and AUTISM SPEAKS, Autistica, SFARI.
Any views expressed are those of the author(s) and not necessarily those of the funders.